Research Advances in Targeted Modulation of Macrophage M1/M2 Polarization for the Treatment of Rheumatoid Arthritis
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/4203230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, online erschienen am 02.11.2026. Verfasst von Hui Zuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing University of Chinese Medicine, Nanjing, 210023, China, njucm.edu.cn. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Macrophages, Macrophage Activation. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a disease of the immune system that leads to continuous synovial inflammation and the progressive breakdown of joints. As essential effector cells in innate immunity, macrophages can become either pro‐inflammatory M1 or anti‐inflammatory M2 phenotypes, playing a critical role in RA pathogenesis. A marked M1/M2 polarization imbalance exists in the synovial microenvironment of RA, in which excessive activation and accumulation of M1 macrophages serve as a key hub driving persistent inflammation, cartilage degradation, and bone erosion. Currently, conventional disease‐modifying antirheumatic drugs (DMARDs) with methotrexate (MTX) as the anchor agent remain the mainstay for RA management; however, approximately 30%‐40% of RA patients show an inadequate response to MTX, resulting in persistent synovial inflammation, progressive joint damage, and difficult‐to‐control disease. For macrophage‐directed phenotypic modulation in RA therapy, novel smart nanodelivery systems are a key research focus, while accumulating preclinical evidence supports the capacity of traditional Chinese medicine (TCM) to restore M1/M2 homeostasis. This review systematically summarizes the polarization mechanisms of macrophages in RA, their core pathological functions, and recent advances in targeting these cells as therapeutic strategies, therefore delivering novel insights and references for RA treatment through targeted changes in macrophage polarization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing University of Chinese Medicine, Nanjing, 210023, China, njucm.edu.cn.
- The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China, njucm.edu.cn.
ORCID-Profile: Hui Zuo, Enqi Fan, Long Zeng, Jun Hu, Jiajia Sang, Feng Hao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zuo, H., Fan, E., Zeng, L., Hu, J., Sang, J., & Hao, F. (2026). Research Advances in Targeted Modulation of Macrophage M1/M2 Polarization for the Treatment of Rheumatoid Arthritis. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/4203230
Vancouver
Zuo H, Fan E, Zeng L, Hu J, Sang J, Hao F. Research Advances in Targeted Modulation of Macrophage M1/M2 Polarization for the Treatment of Rheumatoid Arthritis. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/4203230
BibTeX
@article{Zuo2026,
author = {Zuo, Hui and Fan, Enqi and Zeng, Long and Hu, Jun and Sang, Jiajia and Hao, Feng},
title = {Research Advances in Targeted Modulation of Macrophage M1/M2 Polarization for the Treatment of Rheumatoid Arthritis},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/4203230}
}
EUVIMED